Executive

Hauptinformation

  • Handelsname:
  • Executive
  • Verwenden für:
  • Pflanzen
  • Art der Medizin:
  • Agrochemisch

Dokumenten

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Executive
    Schweiz
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiegruppe:
  • Herbizid

Weitere Informationen

Status

  • Quelle:
  • UFAG - Ufficio federale dell'agricoltura. OFAG - Office fédéral de l'agriculture. BLW - Bundesamt für Landwirtschaft.
  • Zulassungsnummer:
  • I-5445
  • Letzte Änderung:
  • 06-09-2017

Packungsbeilage

Produkt:

Handelsbezeichnung: Executive (Parallelimport)

Produktekategorie

Ausl. Bewilligungsinhaber

Eidg. Zulassungsnummer

Herbizid

DU PONT DE NEMOURS ITALIANA

S.R.L.

I-5445

Packungsbeilagenummer Herkunftsland

Ausl. Zulassungsnummer

4521

Italien

14294

Stoff(e)

Gehalt

Formulierungscode

Wirkstoff: Rimsulfuron

25 %

WG Wasserdispergierbares

Granulat

Anwendungen

A Kultur

Schaderreger/Wirkung

Dosierungshinweise

Auflagen

F Mais

Einjährige Dicotyledonen (Unkräuter)

Einjährige Monocotyledonen

(Ungräser) [inkl. Raigras]

Hirsen

Aufwandmenge: 30 - 40 g/ha

Anwendung: Stadium 12-16

(BBCH).

1, 2

Speise- und

Futterkartoffeln

Einjährige Dicotyledonen (Unkräuter)

Einjährige Monocotyledonen

(Ungräser)

Hirsen

Aufwandmenge: 40 g/ha

Anwendung: Früher

Nachauflauf.

1, 2, 3

Auflagen und Bemerkungen:

Auf der Gebrauchsanweisung ist die Liste der Sorten aufzuführen, welche das Präparat vertragen.

Splitbehandlung möglich (angegebene Aufwandmenge entspricht total bewilligter Menge).

Mit Netzmittelzusatz gemäss Firmenangaben.

Gefahrenkennzeichnungen:

Es gilt die Einstufung und Kennzeichnung der ausländischen Originaletikette.

Zusätzliche Schweizerische Gefahrenkennzeichnungen:

SP 1 Mittel und/oder dessen Behälter nicht in Gewässer gelangen lassen.

Im Zweifelsfall gelten einzig die Originaldokumente der Zulassung. Die Erwähnung eines Produktes,

Wirkstoffes oder einer Firma stellt keine Empfehlung dar und bedeutet nicht, dass sich das Produkt im

Verkauf befindet.

18-12-2017

News on dose dispensing of medicinal products

News on dose dispensing of medicinal products

The Danish executive order on dose dispensing of medicinal products has been updated. Based on the update, the storage period is among other thing extended from 4 to 6 weeks for medicinal products approved for dose dispensing.

Danish Medicines Agency

10-10-2017

DKMA Update October 2017

DKMA Update October 2017

In this issue of DKMA Update, you can read about the decision to change the dispensing status of a number of opioids, about the new guidelines on medicinal cannabis for doctors, and about the executive order on the import of cannabis products.

Danish Medicines Agency

3-7-2017

New fees for medicinal products, pharmaceutical companies and clinical trials from 1 July 2017

New fees for medicinal products, pharmaceutical companies and clinical trials from 1 July 2017

On 1 July 2017, a new executive order on fees payable for medicinal products, pharmaceutical companies and clinical trials became effective. The new fees involve changes in a number of areas.

Danish Medicines Agency

16-6-2017

Eleven new substances on the list of euphoriant substances

Eleven new substances on the list of euphoriant substances

On 15 June 2017, 11 new substances were included in annex 1 of executive order no. 557 of 31 May 2011 on euphoriant substances issued by the Danish Ministry of Health. The information is primarily relevant to companies authorised to deal with euphoriant substances.

Danish Medicines Agency

30-11-2016

Twelve new substances on the list of euphoriant substances

Twelve new substances on the list of euphoriant substances

As of 24 November 2016, 12 new substances are included in the Danish executive order no. 557 of 31 May 2011 on euphoriant substances issued by the Danish Ministry of Health. The information is primarily relevant to companies authorised to deal with euphoriant substances.

Danish Medicines Agency

27-6-2016

New rules governing medicine packages

New rules governing medicine packages

The Danish Medicines Agency has amended the guideline on variations to marketing authorisations and the executive order on product numbers for medicinal products.

Danish Medicines Agency

26-2-2016

New comprehensive list of euphoriant substances regulated in Denmark

New comprehensive list of euphoriant substances regulated in Denmark

You can now find a comprehensive list of euphoriant substances that are subject to control in Denmark via the executive order on euphoriant substances.

Danish Medicines Agency

31-8-2015

Executive order on euphoriant substances – nine new substances

Executive order on euphoriant substances – nine new substances

On 25 August 2015, new substances were included in annex 1 of executive order no. 557 of 31 May 2011 on euphoriant substances issued by the Danish Ministry of Health.

Danish Medicines Agency

11-2-2015

Send Danish package leaflet when applying for changes to product information

Send Danish package leaflet when applying for changes to product information

When applying for changes to the product information, marketing authorisation holders must always send a Danish version of the package leaflet to the Danish Health and Medicines Authority, whether the medicinal product is marketed in Denmark or not (unless the medicinal product is subject to section 11 about omission of the package leaflet, cf. Executive order no. 869 of 21 July 2011, as amended, on the labelling etc. of medicinal products).

Danish Medicines Agency

3-6-2014

Amendment of executive order on euphoriant substances 30 May 2014

Amendment of executive order on euphoriant substances 30 May 2014

On 30 May 2014, the substances below were included in annex 1 of executive order no. 557 of 31 May 2011 on euphoriant substances issued by the Danish Ministry of Health.

Danish Medicines Agency

Es gibt keine Neuigkeiten betreffend dieses Produktes.